Status:
COMPLETED
An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University
Collaborating Sponsors:
MyBiotech Co. Ltd, China
Third Affiliated Hospital, Sun Yat-Sen University
Conditions:
Neuromyelitis Optica Spectrum Disorders
Eligibility:
All Genders
14-80 years
Brief Summary
The diagnostic cohort study could will be use to verify the clinical performance of the AQP4 -immunoglobulin G detection kit and whether it has a good correlation with the clinical diagnosis results. ...
Eligibility Criteria
Inclusion
- The patients who were diagnosed with NMOSD , and the cell-based assay was used to determine the AQP4-IgG-seropositive patients;
- AQP4-IgG is negative in health people with age and sex matching and determined by cell-based assay;
- Female or male, age 14-80;
- Patients or authorized family members volunteered to participate in this study and signed informed consent.
Exclusion
- Patients with coagulation disorders;
- Infection-related encephalitis;
- Immune-related encephalitis;
- A patient with severe mental illness who cannot cooperate clinically;
- A patient with severe jaundice.
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04388072
Start Date
May 15 2020
End Date
February 20 2021
Last Update
February 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology,First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005
2
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, China